Yiqi Du (You Wu)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Helicobacter Pylori

Top Venues

Current cancer drug targets

Journal of digestive diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Yiqi Du, Fenglin Zhang, Panling Xu, Ping Li
Brucine Inhibits Proliferation of Pancreatic Ductal Adenocarcinoma through PI3K/AKT Pathway-induced Mitochondrial Apoptosis. Current cancer drug targets 24 (7) (2024)
Yiqi Du, Fenglin Zhang, Panling Xu, Ping Li
Brucine Inhibits Proliferation of Pancreatic Ductal Adenocarcinoma through PI3K/AKT Pathway-induced Mitochondrial Apoptosis. Current cancer drug targets (2024)
Yiqi Du, Fenglin Zhang, Panling Xu, Ping Li
Brucine Inhibits Proliferation of Pancreatic Ductal Adenocarcinoma through PI3K/AKT Pathway-induced Mitochondrial Apoptosis. Current cancer drug targets 24 (7) (2024)
Yuxin Wang, Huabing Huang, Yuanhang Dong, Zhaoshen Li, Feng Liu, Yiqi Du
Alterations and clinical relevance of gut microbiota in patients with Peutz-Jeghers syndrome: A prospective study. Journal of digestive diseases (2023)
Yiqi Du, Xiao Yang Dong, Xian Zhu Zhou, Zhao-Shen Li, Yi-Qi Du
Effects of probiotics on gastric microbiota and its precombination with quadruple regimen for Helicobacter pylori eradication. Journal of digestive diseases 23 (8-9) (2022)